A randomized, double-blind, placebo-controlled, Phase 2b study to evaluate the safety and efficacy of recombinant human soluble thrombomodulin, ART-123, in patients with sepsis and suspected disseminated intravascular coagulation. (Q39361024)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A randomized, double-blind, placebo-controlled, Phase 2b study to evaluate the safety and efficacy of recombinant human soluble thrombomodulin, ART-123, in patients with sepsis and suspected disseminated intravascular coagulation. |
scientific article |
Statements
A randomized, double-blind, placebo-controlled, Phase 2b study to evaluate the safety and efficacy of recombinant human soluble thrombomodulin, ART-123, in patients with sepsis and suspected disseminated intravascular coagulation (English)
Gordon R Bernard
Mayakonda K Ramesh
Steven P LaRosa
Jan Pachl
Naoki Aikawa
Howard Levy
Joe Hirman
Mradul Daga
Demetrios J Kutsogiannis
Mark Crowther
Joan Vidal Puigserver
Daniel U Blanzaco
Charles T Esmon
Joseph E Parrillo
Louis Guzzi
Seton J Henderson
Parthiv Mehta
Jawed Fareed
Deepak Talwar
Kazuhisa Tsuruta
Kenneth J Gorelick
Yutaka Osawa
1 September 2013